INS and neoplasm: IGFBP1 not only regulates the bioavailability and activity of insulin-like stimuli during embryonic development and tumorigenesis, but has also its own biological activity, including the stimulation of tumor cell motility and adhesion, even in the absence of IGFs (44, 45).